PubMed دسترسی آزاد

Piperine reverses colistin resistance in multidrug resistant Gram-negative pathogens by membrane disruption and ROS damage.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

The global spread of colistin (COL) resistance, particularly mediated by mcr-1, threatens the efficacy of this last-line antibiotic against multidrug-resistant (MDR) Gram-negative pathogens. This development underscores the urgency of developing innovative therapeutic strategies to counteract antimicrobial resistance mechanisms. This study demonstrates that piperine (PIP), a natural alkaloid, functions as a potent adjuvant that restores COL efficacy through a multi-target mechanism. The combination of PIP and COL exhibits significant synergism against clinically relevant pathogens, including mcr-1-positive strains (FICI: 0.07-0.281), and was not susceptible to the development of drug resistance. Additionally, this combination effectively inhibits and eradicates biofilms. Mechanism studies and omics analysis confirmed that PIP combined with COL could cause bacterial membrane disruption, proton motive force (PMF) disruption, efflux pumps inhibition, resulting in accumulation of bacterial reactive oxygen species (ROS) and finally cell death. Furthermore, PIP suppresses MCR-1 through dual suppression of gene expression and protein function. The therapeutic potential was confirmed in murine infection models, where the combination significantly improved survival rates, reduced bacterial loads, and attenuated inflammatory responses. This study provides the first comprehensive elucidation of the multi-target synergy between COL and PIP, offering a promising therapeutic strategy that simultaneously overcomes existing resistance and impedes resistance development.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

MCR-1Piperineantibiotic resistancecolistinsynergistic mechanism
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Pharmacological advances in Candida auris: emerging antifungal mechanisms and next-generation therapeutic strategies.

Candida auris is a major public health concern worldwide due to its efficient transmission, environmental persistence, and broad resistance to approved antifungal classes. This review consolidates recent pharmacological developments in this regard, focusing on mechanistic insights and late-stage therapeutics. Novel agents demonstrate activity against multidrug- and pan-resistant isolates via distinct mechanisms of action and enhanced s…

PubMed2026

Trichodermin exhibits potent anti-glioblastoma activity by inducing cell cycle arrest and apoptosis, suppressing invasion, and enhancing temozolomide efficacy.

Trichodermin, a sesquiterpene antibiotic from Trichoderma species, shows anticancer potential. In this study, anti-glioblastoma activity was evaluated by (3-(4,5-di methyl thiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay, colony formation, lactate dehydrogenase (LDH) release assay, flow cytometry, wound-healing, transwell invasion, adhesion, Western blot, combination-index analysis, and an orthotopic luciferase glioblastoma m…

PubMed2026

Prevalence of primary Helicobacter pylori antibiotic resistance in Europe over the past four decades.

BACKGROUND & AIMS: Antibiotic resistance is a major determinant of the efficacy of Helicobacter pylori (H. pylori) eradication treatment. Our objective was to evaluate the prevalence and geographical distribution of primary antibiotic resistance in patients infected with H. pylori across Europe over the last four decades. METHODS: Bibliographical searches were conducted from 1990 to 2024 in the PubMed database with no language restrict…

PubMed2026

Accuracy and safety of C-TST for tuberculosis infection: A clinical trial in Brazil.

BACKGROUND: Tuberculosis infection (TBI) diagnosis in BCG-vaccinated, high-burden settings remains challenging. RESEARCH QUESTION: We aimed to assess the sensitivity, specificity, and safety of the C-tuberculin skin test (C-TST), compared with PPD RT-23, for tuberculosis infection in BCG-vaccinated adults. STUDY DESIGN AND METHODS: Randomised, double-blind clinical trial in Brazil. Adults with pulmonary tuberculosis (PTB) and asymptoma…